Literature DB >> 24319779

Immune regulation by atypical chemokine receptors.

Robert J B Nibbs, Gerard J Graham.   

Abstract

Chemokines have fundamental roles in regulating immune and inflammatory responses, primarily through their control of leukocyte migration and localization. The biological functions of chemokines are typically mediated by signalling through G protein-coupled chemokine receptors, but chemokines are also bound by a small family of atypical chemokine receptors (ACKRs), the members of which are unified by their inability to initiate classical signalling pathways after ligand binding. These ACKRs are emerging as crucial regulatory components of chemokine networks in a wide range of developmental, physiological and pathological contexts. In this Review, we discuss the biochemical and immunological properties of ACKRs and the potential unifying themes in this family, and we highlight recent studies that identify novel roles for these molecules in development , homeostasis, inflammatory disease, infection and cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319779     DOI: 10.1038/nri3544

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  199 in total

1.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.

Authors:  R J Nibbs; E Kriehuber; P D Ponath; D Parent; S Qin; J D Campbell; A Henderson; D Kerjaschki; D Maurer; G J Graham; A Rot
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Complementary methods provide evidence for the expression of CXCR7 on human B cells.

Authors:  Marie-Luise Humpert; Manuel Tzouros; Sylvia Thelen; Alexandre Bignon; Angélique Levoye; Fernando Arenzana-Seisdedos; Karl Balabanian; Françoise Bachelerie; Hanno Langen; Marcus Thelen
Journal:  Proteomics       Date:  2012-06       Impact factor: 3.984

3.  Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort.

Authors:  K C Horne; X Li; L P Jacobson; F Palella; B D Jamieson; J B Margolick; J Martinson; V Turkozu; K Visvanathan; I J Woolley
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

4.  Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

Authors:  Florian Gebauer; Michael Tachezy; Katharina Effenberger; Katharina von Loga; Hilke Zander; Alexander Marx; Jussuf T Kaifi; Guido Sauter; Jakob R Izbicki; Maximilian Bockhorn
Journal:  J Surg Oncol       Date:  2011-04-25       Impact factor: 3.454

5.  The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization.

Authors:  Aron Chakera; Ruth M Seeber; Alison E John; Karin A Eidne; David R Greaves
Journal:  Mol Pharmacol       Date:  2008-01-29       Impact factor: 4.436

6.  Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.

Authors:  Raffaella Bonecchi; Massimo Locati; Emanuela Galliera; Marisa Vulcano; Marina Sironi; Anna M Fra; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Bodduluri Haribabu; Jo Van Damme; Alberto Mantovani
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

7.  An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis.

Authors:  Veronica Codullo; Helen M Baldwin; Mark D Singh; Alasdair R Fraser; Catherine Wilson; Ashley Gilmour; Axel J Hueber; Claudia Bonino; Iain B McInnes; Carlomaurizio Montecucco; Gerard J Graham
Journal:  Ann Rheum Dis       Date:  2011-02-01       Impact factor: 19.103

8.  CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.

Authors:  Lillian Cruz-Orengo; David W Holman; Denise Dorsey; Liang Zhou; Penglie Zhang; Melissa Wright; Erin E McCandless; Jigisha R Patel; Gary D Luker; Dan R Littman; John H Russell; Robyn S Klein
Journal:  J Exp Med       Date:  2011-02-07       Impact factor: 14.307

9.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

10.  Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population.

Authors:  Boris Julg; Shabashini Reddy; Mary van der Stok; Smita Kulkarni; Ying Qi; Sara Bass; Bert Gold; Michael A Nalls; George W Nelson; Bruce D Walker; Mary Carrington; Thumbi Ndung'u
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

View more
  145 in total

1.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

2.  Transient expression of recombinant ACKR4 (CCRL1) gene, an atypical chemokine receptor in human embryonic kidney (HEK 293) cells.

Authors:  Bahareh Parsi; Abolghasem Esmaeili; Mohammad Hashemi; Mohaddeseh Behjati
Journal:  Mol Biol Rep       Date:  2016-05-11       Impact factor: 2.316

Review 3.  Chemokine signaling in development and disease.

Authors:  John Wang; Holger Knaut
Journal:  Development       Date:  2014-11       Impact factor: 6.868

Review 4.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

Review 5.  Chemokine-guided cell migration and motility in zebrafish development.

Authors:  Jeroen Bussmann; Erez Raz
Journal:  EMBO J       Date:  2015-03-11       Impact factor: 11.598

Review 6.  Role of tyrosine-sulfated proteins in retinal structure and function.

Authors:  Y Kanan; M R Al-Ubaidi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

7.  Comparative modeling and docking of chemokine-receptor interactions with Rosetta.

Authors:  Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman
Journal:  Biochem Biophys Res Commun       Date:  2020-01-07       Impact factor: 3.575

8.  CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima.

Authors:  Mark Roufaiel; Eric Gracey; Allan Siu; Su-Ning Zhu; Andrew Lau; Hisham Ibrahim; Marwan Althagafi; Kelly Tai; Sharon J Hyduk; Kateryna O Cybulsky; Sherine Ensan; Angela Li; Rickvinder Besla; Henry M Becker; Haiyan Xiao; Sanjiv A Luther; Robert D Inman; Clinton S Robbins; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  Nat Immunol       Date:  2016-09-26       Impact factor: 25.606

Review 9.  Immune system modulation of kidney regeneration--mechanisms and implications.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-04-29       Impact factor: 28.314

Review 10.  Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.

Authors:  K E Quinn; D I Mackie; K M Caron
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.